Tower Research Capital »

Fibrobiologics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Fibrobiologics shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $607 460 1.32

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Fibrobiologics

Vanguard Capital Management
Fund Evaluation Group
Geode Capital Management
BlackRock
Cascade Financial Partners
Renaissance Technologies
Vanguard Fiduciary Trust
UBS Group
Goss Wealth Management
Vanguard Global Advisers
Tower Research Capital
Royal Bank of Canada
Islay Capital Management
Advisor Group Holdings
Bnp Paribas Arbitrage, Snc

View all funds holding Fibrobiologics